source
- J&J multiple myeloma drug gains edge in earlier stage diseaseThe latest results studying Talvey in combination with Darzalex Faspro support J&J’s efforts to expand the immunotherapy's use.BioPharma Dive · 1mo ago↗ source
- STAT+: Lilly’s Ajax acquisition may have been worth itA syphilis drug shortage, Sanofi's diabetes drug approval, and more biotech news from The ReadoutSTAT · 1mo ago↗ source
- STAT+: Pharmalittle: We’re reading about Pfizer’s emergency penicillin program, a Sanofi diabetes drug, and morePfizer hasn't complied with a request to donate emergency penicillin to state health agencies as a backstop to prevent congenital syphilisSTAT · 1mo ago↗ source